Pharvaris (PHVS) Enterprise Value Growth (1y) (2020 - 2026)
Pharvaris (PHVS) Enterprise Value Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.22% |
| Dec 31, 2025 | -13.18% |
| Sep 30, 2025 | -14.85% |
| Jun 30, 2025 | 38.94% |
| Mar 31, 2025 | 37.83% |
| Dec 31, 2024 | 28.73% |
| Sep 30, 2024 | -94.43% |
| Jun 30, 2024 | -89.62% |
| Mar 31, 2024 | -175.79% |
| Dec 31, 2023 | -154.94% |
| Sep 30, 2023 | 13.53% |
| Jun 30, 2023 | 9.20% |
| Mar 31, 2023 | 33.63% |
| Dec 31, 2022 | 31.06% |
| Sep 30, 2022 | 22.66% |
| Jun 30, 2022 | 20.45% |
| Mar 31, 2022 | 23.96% |
| Dec 31, 2021 | -103.66% |
| Dec 31, 2020 | -422.66% |